{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:26:01Z","timestamp":1751876761239},"reference-count":29,"publisher":"Bentham Science Publishers Ltd.","issue":"25","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Abundant studies have shown that non-coding RNA is connected\nwith tumor cell growth, migration and invasion. As a newly discovered non-coding\nRNA, WDFY3-AS2 has gradually emerged in the molecular mechanism of various tumors\nand has a potential prospect as a biological indicator of tumor prognosis. This review\ndescribes the pathophysiological mechanism and prognostic value of WDFY3-AS2\nin different cancers.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This review reveals the changes and roles of WDFY3-AS2 in many tumors\nand cancers. The change of WDFY3-AS2 can be used as a cancer biomarker and plays\nan important role in improving tumor growth, migration and invasion. WDFY3-AS2 is\nunique because it can be considered a prognostic marker for many tumors and is of great\nsignificance for clinical diagnosis and treatment. WDFY3-AS2 shows the potential prognostic\nvalue and the prospect of therapeutic targets in various tumors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>PubMed reviewed the related literature to analyze and summarize the regulatory\nmolecular mechanism of WDFY3-AS2 in various tumors and its value as a prognostic\nindicator.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The abnormal expression of LncRNA WDFY3-AS2 in many cancers was connected\nwith the poor prognosis of cancer patients, including diffuse glioma, hepatocellular\ncarcinoma, ovarian cancer, esophageal cancer, triple-negative breast cancer, Clear\nCell Renal Carcinoma, Esophageal squamous cell carcinoma, Lung adenocarcinoma,\nwhich participated in the recovery of orthodontic teeth. WDFY3-AS2 has revealed the\ncellular process of cancer cell growth, migration, and invasion.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The molecular mechanism of LncRNA WDFY3-AS2 regulating tumor specifically\nproves that WDFY3-AS2 has a good prospect in the biological index of prognosis\nor clinical treatment target of cancer patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867329666220909114416","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T09:20:21Z","timestamp":1662974421000},"page":"2814-2821","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["WDFY3-AS2: A Potential Prognostic Factor and Therapeutic Target\nRelated to Cancer"],"prefix":"10.2174","volume":"30","author":[{"given":"Jie","family":"Mou","sequence":"first","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"Medical College, China\nThree Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlan","family":"Chen","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"Medical College, China\nThree Gorges University, Yichang 443002, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinxin","family":"Wu","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"Medical College, China\nThree Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuequan","family":"He","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"Medical College, China\nThree Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, China Three\nGorges University, Yichang, 443002, China"},{"name":"Hubei Clinical Research Center for Functional Digestive Diseases\nof Traditional Chinese Medicine, Yichang Hospital of Traditional Chinese Medicine, Yichang,\n443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfu","family":"Yuan","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"Medical College, China\nThree Gorges University, Yichang 443002, China"},{"name":"Hubei Clinical Research Center for Functional Digestive Diseases\nof Traditional Chinese Medicine, Yichang Hospital of Traditional Chinese Medicine, Yichang,\n443002, China"},{"name":"Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three\nGorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrm.2017.104","volume":"19","author":"Ransohoff J.D.","year":"2018","unstructured":"Ransohoff J.D.; Wei Y.; Khavari P.A.; The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol 2018,19(3),143-157","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gpb.2016.12.005","volume":"15","author":"Dykes I.M.","year":"2017","unstructured":"Dykes I.M.; Emanueli C.; Transcriptional and post-transcriptional gene regulation by long Non-coding RNA. Genom Proteom Bioinform 2017,15(3),177-186","journal-title":"Genom Proteom Bioinform"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/cells8091015","volume":"8","author":"Chi Y.","year":"2019","unstructured":"Chi Y.; Wang D.; Wang J.; Yu W.; Yang J.; Long non-coding RNA in the pathogenesis of cancers. Cells 2019,8(9),1015","journal-title":"Cells"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12935-018-0603-2","volume":"18","author":"Wu F.","year":"2018","unstructured":"Wu F.; Zhao Z.; Chai R.; Liu Y.; Wang K.; Wang Z.; Li G.; Huang R.; Jiang H.; Zhang K.; Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma. Cancer Cell Int 2018,18(1),107","journal-title":"Cancer Cell Int"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.bbrc.2018.07.075","volume":"503","author":"Zhang Z.","year":"2018","unstructured":"Zhang Z.; Wang S.; Liu W.; EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database. Biochem Biophys Res Commun 2018,503(3),1530-1536","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/jcp.29028","volume":"235","author":"Li W.","year":"2020","unstructured":"Li W.; Ma S.; Bai X.; Pan W.; Ai L.; Tan W.; Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer. J Cell Physiol 2020,235(2),1141-1154","journal-title":"J Cell Physiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e0232284","DOI":"10.1371\/journal.pone.0232284","volume":"15","author":"Rodrigues de Bastos D.","year":"2020","unstructured":"Rodrigues de Bastos D.; Nagai M.A.; In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors. PLoS One 2020,15(5),e0232284","journal-title":"PLoS One"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/mc.23396","volume":"61","author":"Zhou X.","year":"2022","unstructured":"Zhou X.; Liu G.; Xu M.; Ying X.; Li B.; Cao F.; Cheng S.; Xiao B.; Cheng M.; Liang L.; Jia M.; Li W.; Liu J.; Li Z.; Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2-miR-21-5p\/miR-221-3p\/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma. Mol Carcinog 2022,61(5),508-523","journal-title":"Mol Carcinog"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"8206","DOI":"10.1111\/jcmm.15488","volume":"24","author":"Zhang Q.","year":"2020","unstructured":"Zhang Q.; Guan F.; Fan T.; Li S.; Ma S.; Zhang Y.; Guo W.; Liu H.; LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p\/SOCS2 axis. J Cell Mol Med 2020,24(14),8206-8220","journal-title":"J Cell Mol Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/mc.23181","volume":"59","author":"Ren P.","year":"2020","unstructured":"Ren P.; Hong X.; Chang L.; Xing L.; Zhang H.; USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p\/ZNF703 axis. Mol Carcinog 2020,59(8),875-885","journal-title":"Mol Carcinog"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13000-019-0802-8","volume":"14","author":"Wood M.D.","year":"2019","unstructured":"Wood M.D.; Halfpenny A.M.; Moore S.R.; Applications of molecular neuro-oncology-a review of diffuse glioma integrated diagnosis and emerging molecular entities. Diagn Pathol 2019,14(1),29","journal-title":"Diagn Pathol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","volume":"15","author":"Molinaro A.M.","year":"2019","unstructured":"Molinaro A.M.; Taylor J.W.; Wiencke J.K.; Wrensch M.R.; Genetic and molecular epidemiology of adult diffuse glioma. Nat Rev Neurol 2019,15(7),405-417","journal-title":"Nat Rev Neurol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"Forner A.","year":"2018","unstructured":"Forner A.; Reig M.; Bruix J.; Hepatocellular carcinoma. Lancet 2018,391(10127),1301-1314","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.5604\/17322693.1184451","volume":"69","author":"Kujawa K.A.","year":"2015","unstructured":"Kujawa K.A.; Lisowska K.M.; Ovarian cancer--from biology to clinic. Postepy Hig Med Dosw 2015,69,1275-1290","journal-title":"Postepy Hig Med Dosw"},{"key":"ref=15","first-page":"561","volume":"91","author":"Penny S.M.","year":"2020","unstructured":"Penny S.M.; Ovarian cancer: An overview. Radiol Technol 2020,91(6),561-575","journal-title":"Radiol Technol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.rpor.2020.07.006","volume":"25","author":"Kolenda T.","year":"2020","unstructured":"Kolenda T.; Guglas K.; Kopczy\u0144ska M.; Soboci\u0144ska J.; Teresiak A.; Bli\u017aniak R.; Lamperska K.; Good or not good: Role of miR-18a in cancer biology. Rep Pract Oncol Radiother 2020,25(5),808-819","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-021-01993-x","volume":"21","author":"Wu Y.","year":"2021","unstructured":"Wu Y.; Wang T.; Xia L.; Zhang M.; LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p\/SDC4 axis. Cancer Cell Int 2021,21(1),284","journal-title":"Cancer Cell Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"43571","DOI":"10.18632\/oncotarget.16721","volume":"8","author":"Hou X.","year":"2017","unstructured":"Hou X.; Wen J.; Ren Z.; Zhang G.; Non-coding RNAs: New biomarkers and therapeutic targets for esophageal cancer. Oncotarget 2017,8(26),43571-43578","journal-title":"Oncotarget"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11748-013-0246-0","volume":"61","author":"Kato H.","year":"2013","unstructured":"Kato H.; Nakajima M.; Treatments for esophageal cancer: A review. Gen Thorac Cardiovasc Surg 2013,61(6),330-335","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9951010","volume":"2021","author":"Kong Q.","year":"2021","unstructured":"Kong Q.; Li G.; Yin G.; Li K.; Zhang D.; Xu W.; Long Noncoding R.N.A.; Long noncoding RNA WDFY3-AS2 represses the progression of esophageal cancer through miR-18a\/PTEN axis. J Oncol 2021,2021,1-12","journal-title":"J Oncol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e2103240118","DOI":"10.1073\/pnas.2103240118","volume":"118","author":"Zhang Y.","year":"2021","unstructured":"Zhang Y.; Narayanan S.P.; Mannan R.; Raskind G.; Wang X.; Vats P.; Su F.; Hosseini N.; Cao X.; Kumar-Sinha C.; Ellison S.J.; Giordano T.J.; Morgan T.M.; Pitchiaya S.; Alva A.; Mehra R.; Cieslik M.; Dhanasekaran S.M.; Chinnaiyan A.M.; Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci USA 2021,118(24),e2103240118","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"Abnet C.C.","year":"2018","unstructured":"Abnet C.C.; Arnold M.; Wei W.Q.; Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 2018,154(2),360-373","journal-title":"Gastroenterology"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1053\/j.gastro.2015.08.054","volume":"149","author":"Ohashi S.","year":"2015","unstructured":"Ohashi S.; Miyamoto S.; Kikuchi O.; Goto T.; Amanuma Y.; Muto M.; Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology 2015,149(7),1700-1715","journal-title":"Gastroenterology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"E653","DOI":"10.21037\/jtd.2016.07.01","volume":"8","author":"Deng H.Y.","year":"2016","unstructured":"Deng H.Y.; Wang Y.C.; Ni P.Z.; Lin Y.D.; Chen L.Q.; Long noncoding RNAs are novel potential prognostic biomarkers for esophageal squamous cell carcinoma: An overview. J Thorac Dis 2016,8(8),E653-E659","journal-title":"J Thorac Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","volume":"293","author":"Kumar P.","year":"2016","unstructured":"Kumar P.; Aggarwal R.; An overview of triple-negative breast cancer. Arch Gynecol Obstet 2016,293(2),247-269","journal-title":"Arch Gynecol Obstet"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"Srigley J.R.","year":"2013","unstructured":"Srigley J.R.; Delahunt B.; Eble J.N.; Egevad L.; Epstein J.I.; Grignon D.; Hes O.; Moch H.; Montironi R.; Tickoo S.K.; Zhou M.; Argani P.; Panel I.R.T.; The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013,37(10),1469-1489","journal-title":"Am J Surg Pathol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/ijms23010151","volume":"23","author":"Rysz J.","year":"2021","unstructured":"Rysz J.; Franczyk B.; \u0141awi\u0144ski J.; Gluba-Brz\u00f3zka A.; Characteristics of clear cell papillary renal cell carcinoma (ccpRCC). Int J Mol Sci 2021,23(1),151","journal-title":"Int J Mol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13244-020-00875-6","volume":"11","author":"Lambe G.","year":"2020","unstructured":"Lambe G.; Durand M.; Buckley A.; Nicholson S.; McDermott R.; Adenocarcinoma of the lung: From BAC to the future. Insights Imag 2020,11(1),69","journal-title":"Insights Imag"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2353\/jmoldx.2007.060182","volume":"9","author":"Finberg K.E.","year":"2007","unstructured":"Finberg K.E.; Sequist L.V.; Joshi V.A.; Muzikansky A.; Miller J.M.; Han M.; Beheshti J.; Chirieac L.R.; Mark E.J.; Iafrate A.J.; Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features. J Mol Diagn 2007,9(3),320-326","journal-title":"J Mol Diagn"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220909114416","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208712\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220909114416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:59:12Z","timestamp":1693684752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208712\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":29,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220909114416","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}